Potentiation of neuronal insulin signaling and glucose uptake by resveratrol: The involvement of AMPK

Pharmacological Reports

Volumn 63, Issue 5, 2011, Pages 1162-1168

  Patel, Mayur I ^a   Gupta, Amit ^a,b   Dey, Chinmoy S ^a,c  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

^b TATA INSTITUTE OF FUNDAMENTAL RESEARCH   (India)

^c INDIAN INSTITUTE OF TECHNOLOGY DELHI   (India)

Author keywords

AMPK; Glucose uptake; Neuronal insulin signaling; Resveratrol

Indexed keywords

ADENYLATE KINASE; GLUCOSE; GLYCOGEN SYNTHASE KINASE 3BETA; INSULIN; PROTEIN KINASE B; RESVERATROL;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DENSITOMETRY; DISEASE ASSOCIATION; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; ENZYME PHOSPHORYLATION; GLUCOSE TRANSPORT; IMMUNOBLOTTING; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION;

EID: 83155181924     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(11)70635-1     Document Type: Article

References (31)

1. Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y: Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res, 2004, 24, 2783-2840. (Pubitemid 39409568)
2. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV et al.: Resveratrol improves health and survival of mice on a high-calorie diet. Nature, 2006, 444, 337-342. (Pubitemid 44764104)
3. Benomar Y, Naour N, Aubourg A, Bailleux V, Gertler A, Djiane J, Guerre-Millo M et al.: Insulin and leptin induce Glut4 plasma membrane translocation and glucose uptake in a human neuronal cell line by a phosphatidylinositol 3-kinase-dependent mechanism. Endocrinology, 2006, 147, 2550-2556.
4. Bertrand L, Ginion A, Beauloye C, Hebert AD, Guigas B, Hue L, Vanoverschelde JL: AMPK activation restores the stimulation of glucose uptake in an in vitro model of insulin-resistant cardiomyocytes via the activation of protein kinase B. Am J Physiol Heart Circ Physiol, 2006, 291, H239-250.
5. Breen DM, Sanli T, Giacca A, Tsiani E: Stimulation of muscle cell glucose uptake by resveratrol through sirtuins and AMPK. Biochem Biophys Res Commun, 2008, 374, 117-122.
6. Brozinick JT Jr, Birnbaum MJ: Insulin, but not contraction, activates Akt/PKB in isolated rat skeletal muscle. J Biol Chem, 1998, 273, 14679-14682.
7. Carroll R, Carley AN, Dyck JR, Severson DL: Metabolic effects of insulin on cardiomyocytes from control and diabetic db/db mouse hearts. Am J Physiol Endocrinol Metab, 2005, 288, E900-906. (Pubitemid 40547883)
8. Cowley S, Paterson H, Kemp P, Marshall CJ: Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell, 1994, 77, 841-852. (Pubitemid 24187682)
9. Culmsee C, Monnig J, Kemp BE, Mattson MP: AMPactivated protein kinase is highly expressed in neurons in the developing rat brain and promotes neuronal survival following glucose deprivation. J Mol Neurosci, 2001, 17, 45-58. (Pubitemid 32928285)
10. Fediuc S, Gaidhu MP, Ceddia RB: Regulation of AMPactivated protein kinase and acetyl-CoA carboxylase phosphorylation by palmitate in skeletal muscle cells. J Lipid Res, 2006, 47, 412-420. (Pubitemid 43276927)
11. Fryer LG, Hajduch E, Rencurel F, Salt IP, Hundal HS, Hardie DG, Carling D: Activation of glucose transport by AMP-activated protein kinase via stimulation of nitric oxide synthase. Diabetes, 2000, 49, 1978-1985.
12. Fulco M, Sartorelli V: Comparing and contrasting the roles of AMPK and SIRT1 in metabolic tissues. Cell Cycle, 2008, 7, 3669-3679.
13. Funai K, Cartee GD: Inhibition of contraction-stimulated AMP-activated protein kinase inhibits contractionstimulated increases in PAS-TBC1D1 and glucose transport without altering PAS-AS160 in rat skeletal muscle. Diabetes, 2009, 58, 1096-1104.
14. Gaidhu MP, Fediuc S, Ceddia RB: 5-Aminoimidazole-4- carboxamide-1-β- D-ribofuranoside-induced AMP-activated protein kinase phosphorylation inhibits basal and insulin-stimulated glucose uptake, lipid synthesis, and fatty acid oxidation in isolated rat adipocytes. J Biol Chem, 2006, 281, 25956-25964. (Pubitemid 44401801)
15. Gupta A, Bisht B, Dey CS: Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes. Neuropharmacology, 2011, 60, 910-920.
16. Gupta A, Dey CS: PTEN and SHIP2 regulates PI3K/Akt pathway through focal adhesion kinase. Mol Cell Endocrinol, 2009, 309, 55-62.
17. Kohn AD, Summers SA, Birnbaum MJ, Roth RA: Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J Biol Chem, 1996, 271, 31372-31378. (Pubitemid 26408588)
18. Kramer HF, Witczak CA, Fujii N, Jessen N, Taylor EB, Arnolds DE, Sakamoto K et al.: Distinct signals regulate AS160 phosphorylation in response to insulin, AICAR, and contraction in mouse skeletal muscle. Diabetes, 2006, 55, 2067-2076. (Pubitemid 44509981)
19. Park CE, Kim MJ, Lee JH, Min BI, Bae H, Choe W, Kim SS et al.: Resveratrol stimulates glucose transport in C2C12 myotubes by activating AMP-activated protein kinase. Exp Mol Med, 2007, 39, 222-229. (Pubitemid 46683408)
20. Porte D Jr, Baskin DG, Schwartz MW: Insulin signaling in the central nervous system: a critical role in metabolic homeostasis and disease from C. elegans to humans. Diabetes, 2005, 54, 1264-1276. (Pubitemid 40586653)
21. Rizvi SI, Pandey KB: Activation of the erythrocyte plasma membrane redox system by resveratrol: a possible mechanism for antioxidant properties. Pharmacol Rep, 2010, 62, 726-732.
22. Ronnett GV, Ramamurthy S, Kleman AM, Landree LE, Aja S: AMPK in the brain: its roles in energy balance and neuroprotection. J Neurochem, 2009, 109, 17-23.
23. Smith JL, Patil PB, Fisher JS: AICAR and hyperosmotic stress increase insulin-stimulated glucose transport. J Appl Physiol, 2005, 99, 877-883. (Pubitemid 41214497)
24. Spasic MR, Callaerts P, Norga KK: AMP-activated protein kinase (AMPK) molecular crossroad for metabolic control and survival of neurons. Neuroscientist, 2009, 15, 309-316.
25. Sun C, Zhang F, Ge X, Yan T, Chen X, Shi X, Zhai Q: SIRT1 improves insulin sensitivity under insulinresistant conditions by repressing PTP1B. Cell Metab, 2007, 6, 307-319. (Pubitemid 47468091)
26. Tao R, Gong J, Luo X, Zang M, Guo W, Wen R, Luo Z: AMPK exerts dual regulatory effects on the PI3K pathway. J Mol Signal, 2010, 5, 1.
27. Um JH, Park SJ, Kang H, Yang S, Foretz M, McBurney MW, Kim MK et al.: AMP-activated protein kinasedeficient mice are resistant to the metabolic effects of resveratrol. Diabetes, 2010, 59, 554-563.
28. van der Heide LP, Ramakers GM, Smidt MP: Insulin signaling in the central nervous system: learning to survive. Prog Neurobiol, 2006, 79, 205-221. (Pubitemid 44331498)
29. Vingtdeux V, Giliberto L, Zhao H, Chandakkar P, Wu Q, Simon JE, Janle EM et al.: AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-βpeptide metabolism. J Biol Chem, 2010, 285, 9100-9113.
30. Zamin LL, Dillenburg-Pilla P, Argenta-Comiran R, Horn AP, Simao F, Nassif M, Gerhardt D et al.: Protective effect of resveratrol against oxygen-glucose deprivation in organotypic hippocampal slice cultures: Involvement of PI3-K pathway. Neurobiol Dis, 2006, 24, 170-182. (Pubitemid 44416216)
31. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M et al.: Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest, 2001, 108, 1167-1174. (Pubitemid 32995375)